FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083
March 02, 2015
DelMar Pharmaceuticals to Present Clinical and Preclinical Abstracts for VAL-083 at the American Association of Cancer Research (AACR) Annual Meeting in April 2015
February 24, 2015
DelMar Pharmaceuticals Announces December 31, 2014 Financial Results and Provides Corporate Update
February 12, 2015
DelMar Pharmaceuticals Appoints Lynda Cranston, BScN, MScN, ICD.D, to the Board of Directors
February 11, 2015
DelMar Pharmaceuticals Completes Offer to Exchange Common Stock for Outstanding Warrants
February 10, 2015
DelMar Pharmaceuticals Receives Notice of Allowance for Third US Patent for VAL-083
January 13, 2015
DelMar Pharmaceuticals Provides Update on VAL-083 Clinical Trial and Outlines Corporate Objectives for 2015
January 12, 2015
DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for Outstanding Warrants
January 08, 2015
DelMar Pharmaceuticals to Present at Biotech Showcase™ 2015
January 07, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here